Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6301–6350 of 75459
Also effective April 20, 2025, Renee Barnett ceased serving as the Chief Financial Officer (including the principal financial officer and principal accounting officer) of the Company.
Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc. (the “Company”), announced her intention to transition into an advisory role with Hims & Hers in the coming months.
On April 17, 2025, Troy Vanke, Chief Accounting Officer of Playtika Holding Corp. (the “Company”), informed the Company of his intent to retire and to resign from his position, effective June 30, 2025.
Jost Fisher will step down as Interim President and Chief Executive Officer but will continue to serve as chairman of the Board, a member of the audit committee and chair of the compensation committee.
On April 19, 2025, the board of directors (the “Board”) of AEON BioPharma, Inc. (the “Company”) appointed Robert Bancroft, age 60, as the Company’s Principal Executive Officer, President, Chief Executive Officer and member of the Board to serve as a Class I director, effective as of April 29, 2025.
the Board appointed Steven C. Crouse and Philip J. Gotwals, Ph.D. to the Board
the Board appointed Steven C. Crouse and Philip J. Gotwals, Ph.D. to the Board
On April 21, 2025, the Board of Directors (the "Board") of Rivian Automotive, Inc. (the "Company") increased the size of the Board and elected Aidan Gomez to serve as a Class II director of the Company with a term expiring at the 2026 annual meeting of stockholders, effective immediately.
On April 21, 2025, Burke & Herbert Financial Services Corp. (the “Company”) announced the appointment of Patrick “Kip” Huffman, CPA, as Senior Vice President and Chief Accounting Officer.
Effective July 1, 2025, Mr. Shigemura will assume the position of Internal Consultant to the Company for one year at an annual salary of $500,000.
Vice Chair and Chief Financial Officer (“CFO”) Dean Y. Shigemura, 61, will step down as CFO effective June 30, 2025.
When Mr. Shigemura exits his current role, his duties as CFO will be assumed by current Senior Executive Vice President and Deputy CFO Bradley S. Satenberg.
On April 18, 2025, Mr. Greg Petersen resigned as a member of the Board. Mr. Petersen informed the Company that his resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
On April 18, 2025, the Board of Directors (the “Board”) of Plus Therapeutics, Inc (the “Company”) unanimously appointed Mr. Kyle Guse to serve as a director of the Board, effective immediately.
Robert Hofmeister, Ph.D. Resignation On April 15, 2025, Dr. Hofmeister resigned as a member of the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) with immediate effect.
In connection with Mr. Ellwein's resignation, the Company's Board of Directors has appointed Brian Baker as Chief Financial Officer (principal financial officer and principal accounting officer) of the Company, effective as of May 9, 2025.
On April 15, 2025 Gabe Ellwein informed Dynatronics Corporation (the "Company") of his decision to resign as Chief Financial Officer (principal financial officer and principal accounting officer) of the Company, effective as of May 9, 2025, to pursue other professional interests.
On April 4, 2025, the Board of Directors of the Company voted unanimously to appoint Eric Maire to the Board as an Independent Director.
On April 15, 2025, Robert E. Knowling Jr. notified the Board of Directors (the “Board”) of Stride, Inc. (the “Company”) of his decision to resign from the Board and all committees on which he served, effective immediately.
On March 13, 2025, The Cigna Group (the “Company”) filed a Form 8-K disclosing that the employment of Eric P. Palmer, Executive Vice President for Enterprise Strategy, The Cigna Group and President and Chief Executive Officer, Evernorth Health Services, will end April 26, 2025.
On April 15, 2025, Kristin L. Oliver, Chief Legal Officer, Chief Human Resources Officer, and Executive Vice President of Communications of Hanesbrands Inc. (the “Company”), notified the Company that she intends to leave the Company to pursue another business opportunity, effective May 9, 2025.
On April 17, 2025, Mr. Fraser notified the Windtree Therapeutics, Inc.(the “ Company ”) Board of Directors (the “ Board ”) of his resignation from the Board, effective immediately.
On April 18, 2025, the Board of Directors of Two Harbors Investment Corp. (the “Company”) confirmed that William Dellal has been designated as the Company’s Vice President and Chief Financial Officer and will serve in such role until further notice.
On April 18, 2025, Vera Bradley, Inc. (the “Company”) announced that long-time board member Frances P. Philip will not stand for re-election at the upcoming 2025 Shareholder Meeting.
The Board of Directors of Juniata Valley Financial Corp. (the “Company”) appointed John Henry IV as a director of the Company on April 15, 2025.
On March 17, 2025, Avanos Medical, Inc. (the “Company”) announced the appointment of David Pacitti as the Company’s Chief Executive Officer, effective April 14, 2025.
Mr. Machan no longer serves as the Company’s Interim Chief Financial Officer effective April 14, 2025
The Company has appointed Jason M. Pickett as Interim Chief Financial Officer and Treasurer, effective April 14, 2025.
On April 18, 2025, Michael C. Greiner announced that he will leave Avanos Medical, Inc. (the “Company”) to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.
On April 15, 2025,Dexter Fowler and Jennifer Prince notified the Board of Directors (the “Board”) of System1, Inc. (the “Company”) of their respective resignation from the Board, effective as of the close of business on April 15, 2025.
On April 15, 2025,Dexter Fowler and Jennifer Prince notified the Board of Directors (the “Board”) of System1, Inc. (the “Company”) of their respective resignation from the Board, effective as of the close of business on April 15, 2025.
On April 17, 2025, we appointed Mr. Theo Davies, as our Chief Revenue Officer (CRO), effective immediately.
On April 17, 2025, a new independent director was appointed as member of the Board of Directors (the “Board”) of Alixo-Yolloo Corporation (the “Company”).
On April 15, 2025, Messrs. William C. Mulligan and Edward K. Zinser announced their intention to not stand for re-election at the 2026 Annual Meeting.
On April 15, 2025, the Board of Directors (the “Board”) of Universal Electronics Inc. (“UEI” or the “Company”) appointed John Mutch as a director, effective immediately, to fill a vacancy.
On April 15, 2025, Messrs. William C. Mulligan and Edward K. Zinser announced their intention to not stand for re-election at the 2026 Annual Meeting.
Evan T. Scott has been appointed Chief Financial Officer to replace Mr. Malave effective April 17, 2025.
Jay Malave, its Chief Financial Officer, advised the Company of his intention to pursue other opportunities outside of the Company.
On April 17, 2025, Spirit Aviation Holdings, Inc. (“Spirit” or the “Company”) announced the appointment of David Davis as President, Chief Executive Officer of the Company and as a member of the Board of Directors of the Company (the “Board”), in each case to be effective April 21, 2025.
On April 16, 2025, Patrick Goris, Senior Vice President and Chief Financial Officer of the Company, agreed to become interim Controller of the Company, effective May 2, 2025, while a search for a permanent replacement is conducted.
On April 16, 2025, Kyle Crockett, Vice President, Controller and Chief Accounting Officer of Carrier Global Corporation (the “Company”), informed the Company that he is resigning to pursue another opportunity.
his resignation from the AGM Board will be effective as of April 21, 2025.
appointed Mr. Marc Rowan, Chief Executive Officer of AGM, to serve as Chair of the Board, effective as of April 21, 2025.
Mr. Gary Cohn will serve as Lead Independent Director of the Board of Directors (the “Board”) of Apollo Global Management, Inc. (“AGM”), effective as of April 21, 2025
On April 16, 2025, Richard Parisi and Elizabeth LaPuma delivered notice to the board of directors (the “Board”) of ContextLogic Inc. (the “Company”) of their resignation as directors, effective immediately, to pursue other opportunities.
On April 16, 2025, Richard Parisi and Elizabeth LaPuma delivered notice to the board of directors (the “Board”) of ContextLogic Inc. (the “Company”) of their resignation as directors, effective immediately, to pursue other opportunities.
On April 16, 2025, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Michael Grissinger to the Board, effective as of April 17, 2025, to fill the vacancy resulting from Dr. Gordon’s resignation.
On April 14, 2025, Carl L. Gordon, Ph.D., a Class II member of the board of directors (the “Board”) of Adicet Bio, Inc. (the “Company”), notified the Company of his resignation from the Board and Compensation Committee of the Board (the “Compensation Committee”), effective on April 17, 2025.
On April 11, 2025, D. Gary Gilliland, M.D., Ph.D., a member of the board of directors (the “Board”) of Nuvalent, Inc. (the “Company”), notified the Company of his decision to resign from the Board and from all committees of the Board on which he serves, effective as of the date and time of the Company’s 2025 annual meeting of stockholders.
On April 11, 2025, Timothy Haley informed the Company of his decision to not stand for re-election as a director at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”).
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.